Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells

Condition:   Diabetes Mellitus, Type 1 Interventions:   Biological: Mesenchymal Stem Cells (MSCs);   Other: Placebo Infusion (Plasmalyte A with 0.5% human serum albumin) Sponsors:   Medical University of South Carolina;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials